home / stock / snbp / snbp quote
Last: | $3.19 |
---|---|
Change Percent: | -66.42% |
Open: | $3.3 |
Close: | $3.19 |
High: | $3.6 |
Low: | $3.16 |
Volume: | 540,134 |
Last Trade Date Time: | 08/28/2020 04:54:40 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.19 | $3.3 | $3.19 | $3.6 | $3.16 | 540,134 | 08-28-2020 |
$9.5 | $9.5 | $9.5 | $9.5 | $9.5 | 126 | 08-27-2020 |
$9.25 | $9.75 | $9.25 | $9.75 | $9 | 880 | 08-26-2020 |
$9.49 | $9.5 | $9.49 | $9.5 | $9.49 | 368 | 08-24-2020 |
$7.75 | $7.75 | $7.75 | $7.75 | $7.75 | 225 | 08-21-2020 |
$7 | $7 | $7 | $7 | $7 | 515 | 08-20-2020 |
$8.75 | $9.5 | $8.75 | $9.5 | $8.75 | 1,810 | 08-17-2020 |
$9.5 | $9.5 | $9.5 | $9.5 | $9.5 | 182 | 08-14-2020 |
$9.5 | $9.5 | $9.5 | $9.5 | $9.5 | 500 | 08-13-2020 |
$9.5 | $9.46 | $9.5 | $9.5 | $9.46 | 1,027 | 08-12-2020 |
$8.75 | $8.75 | $8.75 | $8.75 | $8.75 | 200 | 08-11-2020 |
$7.75 | $7.75 | $7.75 | $7.75 | $7.75 | 100 | 08-07-2020 |
$7.75 | $7.75 | $7.75 | $7.75 | $7.75 | 244 | 08-06-2020 |
$6.3 | $7.26 | $6.3 | $7.26 | $6.3 | 308 | 07-24-2020 |
$9.5 | $9.5 | $9.5 | $9.5 | $9.5 | 625 | 07-22-2020 |
$8 | $8 | $8 | $8 | $8 | 112 | 07-21-2020 |
$9.5 | $9.5 | $9.5 | $9.5 | $9.01 | 2,431 | 07-15-2020 |
$10 | $8 | $10 | $10 | $8 | 1,785 | 07-14-2020 |
$7.5 | $7 | $7.5 | $7.5 | $6.8 | 946 | 07-10-2020 |
$6.5 | $6.5 | $6.5 | $6.5 | $6.325 | 430 | 07-08-2020 |
News, Short Squeeze, Breakout and More Instantly...
MINNEAPOLIS, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, has completed patient enrollment in its Phase 1 trial evaluating the s...
MINNEAPOLIS, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, has announced the change of its corporate name to Panbela Therapeutics, Inc. effective ...
MINNEAPOLIS, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic cancer, today provides a business update and reports financial results for the quart...